The company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Securities Code: 301239
Securities Abbreviation: Puri Eye Hospital
Announcement Number: 2026-011
Important Content Reminder:
-
Types of Cash Management: Puri Eye Hospital Group Co., Ltd. (hereinafter referred to as "the Company") intends to use idle raised funds (including overraised funds) and self-owned funds for cash management. The raised funds will be used to purchase cash management products that are highly secure, liquid, low-risk, and with a maturity of no more than 12 months, including but not limited to principal-protected structured deposits and principal-protected agreed deposits. This will not affect the normal investment plans of the raised funds; self-owned funds will also be used to purchase highly secure and liquid cash management products.
-
Amount for Cash Management: To improve the efficiency of fund utilization, the Company plans to use no more than RMB 400 million (including principal) of idle raised funds (including overraised funds) and no more than RMB 600 million (including principal) of self-owned funds for cash management, ensuring that it does not affect the normal operation of the investment plans or the Company's operations and ensures fund safety. Within the above limits, funds can be used on a rolling basis, with a term from the expiration date of the previous authorization for cash management of idle raised funds and self-owned funds, from April 22, 2026, to April 21, 2027.
-
Special Risk Reminder: The use of temporarily idle raised funds (including overraised funds) and self-owned funds for cash management is subject to risks such as macroeconomic fluctuations and investment returns not meeting expectations. Investors are advised to pay attention to investment risks.
On April 7, 2026, the Company held the second meeting of the fourth board of directors, which reviewed and approved the proposal on the use of temporarily idle raised funds (including overraised funds) and self-owned funds for cash management, agreeing that the Company and its subsidiaries could use no more than RMB 400 million (including principal) of idle raised funds (including overraised funds) and no more than RMB 600 million (including principal) of self-owned funds for cash management without affecting the investment plans of the raised funds.
Basic Situation of Raised Funds
According to the approval from the China Securities Regulatory Commission regarding the registration of the initial public offering of Chengdu Puri Eye Hospital Co., Ltd. (Zheng Jian Xu Ke [2022] No. 587), the Company issued 37,404,762 shares of RMB ordinary shares (A shares) at a par value of RMB 1.00 per share, with an issue price of RMB 33.65 per share, raising a total of RMB 1,258,670,241.30. After deducting issuance costs (including tax), the actual net amount raised was RMB 1,098,935,692.69. Tianjian Accounting Firm (Special General Partnership) verified the raised funds on June 27, 2022, and issued the verification report Tianjian Yan [2022] No. 314. The Company has opened a special account for the raised funds, stored the raised funds in a dedicated account, and signed a supervision agreement for the raised funds with the bank where the special account is opened and the sponsor institution. All raised funds have been deposited in the Company's special account as required.
Use and Management of Raised Funds
As of the date of this announcement, the investment projects funded by the raised funds from the initial public offering are as follows: